Other known mechanisms that may impact tumor antigenicity are defects in antigen-presentation and overexpression of immunosuppressive molecules, such as CD47, PD-L1, and indolamine-2,3-dioxygenase [42, 43, 75]. Here, CD274 is linked to neoplasm.